Xuewu Sun
Sir Run Run Shaw Hospital, P.R. China
Hangzhou, 310016, China
Hangzhou, 310016, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Human papillomavirus E7 inhibits immune responses in keratinocytes by activating HTRA1‑mediated mitophagy.
Journal: International journal of molecular medicine
Published: July 04, 2025
Visomitin Attenuates Pathological Bone Loss by Reprogramming Osteoclast Metabolism via the STAT3/LDHB Axis.
Journal: Research (Washington, D.C.)
Published: April 18, 2025
Irg1 regulates bone homeostasis via regulating the Grk5 expression.
Journal: Biochemical and biophysical research communications
Published: September 09, 2024
Publisher Correction: Restrained Mitf-associated autophagy by Mulberroside A ameliorates osteoclastogenesis and counteracts OVX-Induced osteoporosis in mice.
Journal: Cell death discovery
Published: July 09, 2024
Restrained Mitf-associated autophagy by Mulberroside A ameliorates osteoclastogenesis and counteracts OVX-Induced osteoporosis in mice.
Journal: Cell death discovery
Published: April 24, 2023
Metabolite asymmetric dimethylarginine (ADMA) functions as a destabilization enhancer of SOX9 mediated by DDAH1 in osteoarthritis.
Journal: Science advances
Published: February 08, 2023
ERK1 loss accelerates the progression of osteoarthritis in aged mice via NRF2/BACH1 signaling.
Journal: Biochemical and biophysical research communications
Published: June 16, 2022
USP1 inhibition suppresses the progression of osteosarcoma via destabilizing TAZ.
Journal: International journal of biological sciences
Published: July 27, 2021
DUSP6 expression is associated with osteoporosis through the regulation of osteoclast differentiation via ERK2/Smad2 signaling.
Journal: Cell death & disease
Published: February 21, 2021
Oxidative Stress-Induced Hypermethylation of KLF5 Promoter Mediated by DNMT3B Impairs Osteogenesis by Diminishing the Interaction with β-Catenin.
Journal: Antioxidants & redox signaling
Published: February 16, 2021
The Novel p38 Inhibitor, Pamapimod, Inhibits Osteoclastogenesis and Counteracts Estrogen-Dependent Bone Loss in Mice.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Published: May 18, 2020
Last Updated: 09/26/2026